The patient required amputation on the treated limb.This is being reported as a follow-up to the clinical registry.Patient information regarding relevant tests or laboratory data is unknown.This information was not available from the facility.The lot number was not provided in the registry, thus the following information are unknown: unique id, model #, catalog #, expiration date, and manufacture date (b)(6).Pma number is not applicable.The device is a commercial product with a ce mark that was used as part of a clinical registry.During the index procedure, the product worked as intended and the device was discarded, thus no product evaluation was required.Per the ifu, necrosis, infection, and amputation are listed as potential complications/adverse events.
|
It was reported through a clinical registry that during the index procedure on (b)(6) 2019, a stellarex catheter was used to treat the target lesion of the right distal sfa.Approximately 2 months post index procedure, the patient experienced complications of fontaine stage iv (necrosis and gangrene).A transgenual amputation of the target limb was performed on (b)(6) 2019.Approximately 1 month later, the patient experienced an infection of the previous amputation site and a transfemoral amputation of the target limb was performed on (b)(6) 2020.
|